The WOUND LITE panel includes detection of key bacterial pathogens such as Enterococcus spp., Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus agalactiae (Group B), Streptococcus pyogenes (Group A), as well as resistance genes for Methicillin/Oxacillin (mecA) and Vancomycin (vanA & vanB).

By covering these significant pathogens, the Express Gene™ WOUND LITE panel ensures comprehensive screening of wound infections, facilitating prompt and accurate identification. This aids clinicians in choosing the most effective treatment options, minimizing the risk of complications and promoting faster healing. The inclusion of resistance gene detection helps in tailoring antibiotic therapy, improving patient outcomes, and combating antibiotic resistance.

The Express Gene™ WOUND LITE panel is an invaluable diagnostic tool for healthcare providers focused on delivering targeted and efficient care for patients with wound infections, ensuring better recovery and overall health.